热门资讯> 正文

Annovis Bio GAAP每股收益为-0.37美元

2025-11-12 22:18

Annovis Bio(ANVS) 0

Annovis Bio press release (ANVS): Q3 GAAP EPS of -$0.37.
Annovis’ cash and cash equivalents totaled $15.3 million as of September 30, 2025, compared to $10.6 million as of December 31, 2024.

More on Annovis Bio

Seeking Alpha’s Quant Rating on Annovis Bio
Historical earnings data for Annovis Bio
Financial information for Annovis Bio

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。